GemPharmatech Co., Ltd. (SHA:688046)
China · Delayed Price · Currency is CNY 17.43
-0.16 (-0.91%)
At close: Feb 12, 2026
GemPharmatech Market Cap
GemPharmatech has a market cap or net worth of 6.98 billion as of February 13, 2026. Its market cap has increased by 30.81% in one year.
Market Cap
6.98B
Enterprise Value
6.11B
Revenue
793.25M
Ranking
n/a
PE Ratio
48.63
Stock Price
17.43
Market Cap Chart
Since April 25, 2022, GemPharmatech's market cap has decreased from 7.59B to 6.98B, a decrease of -8.00%. That is a compound annual growth rate of -2.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 6.98B | 10.81% |
| Dec 31, 2025 | 6.30B | 19.98% |
| Dec 31, 2024 | 5.25B | -36.47% |
| Dec 29, 2023 | 8.26B | -16.22% |
| Dec 30, 2022 | 9.86B | 30.00% |
| Apr 25, 2022 | 7.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Ausun Pharmaceutical | 8.05B |
| Suzhou Fengbei Biotech Stock | 7.92B |
| Wuhan Keqian Biology Co.,Ltd | 7.60B |
| R&G PharmaStudies | 7.45B |
| Jiangsu Aidea Pharmaceutical Group | 7.07B |
| Shenzhen Weiguang Biological Products | 7.00B |
| Shanghai OPM Biosciences | 6.96B |
| Beijing Konruns Pharmaceutical | 6.72B |